Investigating genetic differences in twins with and without Down syndrome
Official title: Genetic and Epigenetic Variations in Heterokaryotypic Monozygotic Twins Discordant for Down Syndrome
Run by Institut Jerome Lejeune · NCT05767216 · Data updated 2026-11-12
This study is trying to understand the genetic differences between twins, one with Down syndrome and one without, to see how these differences might affect their health and development.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 4 Years to 11 Years |
| Sex | Men only |
| Enrollment | 5 (estimated) |
| Sponsor | Institut Jerome Lejeune Academic / other |
| Locations | 1 site (Paris) |
| Status | Recruiting |
| Started | December 20, 2022 |
| Main results expected | December 30, 2023 |
| Study ends | December 30, 2028 |
| Registry record updated | March 14, 2023 |
| Trial ID | NCT05767216 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include heterokaryotypic monozygotic twins discordant for Down syndrome and age-matched dizygotic twins or patients with mosaic Down syndrome.
✕Probably not a fit
Patients who are not part of a heterokaryotypic monozygotic twin pair or do not have a genetic connection to Down syndrome may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on heterokaryotypic monozygotic twins who are discordant for Down syndrome, aiming to explore genetic and epigenetic variations between them. By conducting multi-omics analyses, researchers will assess how genomic changes affect protein expression and biochemical modifications, while also examining the influence of environmental factors. The study will generate induced pluripotent stem cells from the twins' blood and fibroblasts to create in-vitro models for further investigation into Down syndrome pathogenesis. Additionally, the human gut microbiome will be analyzed for its potential role in health and disease.
Why it matters
Potential benefit: If successful, this research could lead to new insights and therapeutic approaches for Down syndrome.
How similar studies have gone: While studies on twins and genetic variations exist, this specific approach focusing on heterokaryotypic monozygotic twins is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Twins of a heterokaryotypic monozygotic pair discordant for DS * Twins of a sex- and class of age-matched dizygotic pair discordant for DS, * Sex- and class of age-matched patient with mosaic T21 * Subject's parents/legal representatives willing to give written informed consent. * Subject and his/her parents/legal representatives must be able/willing to comply with the protocol. * Subject covered by social welfare. Exclusion Criteria: * None
Where it's running
-
Institut Jérôme Lejeune
Paris, France Recruiting
Study contacts
- Study coordinator: Sophie Durand
- Email: sophie.durand@institutlejeune.org
- Phone: 0033156586300
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Kinematic analysis of hand and arm movement in kids with Down syndrome, CP and healthy children
This study tests how well an instrumented Box and Block Test and motion tracking can measure upper-limb movement in healthy kids and those with pyramidal hemisyndrome or Down syndrome.
-
Sensory integration to help balance and movement in kids with Down syndrome
Aimed at seeing if adding sensory integration to physical therapy helps improve gross motor skills and balance in children with Down syndrome.
-
Collaboration for Down Syndrome Progress (CDP) in people with Down syndrome
A long-term study following people with Down syndrome of all ages to see how health and everyday life change over time.
-
JAK inhibitor treatment for Down syndrome in children and young adults
This study tests whether 6 months of tofacitinib can help improve safety and neurodevelopment in people with Down syndrome aged 6 to 22, compared with placebo.
-
Jump rope to improve navicular drop and foot posture in children with Down syndrome
This project will test whether adding jump-rope exercises to play activities helps improve foot posture in 4–15-year-old children with Down syndrome who have navicular drop.
-
Thymus removal and immune aging in people with Down syndrome
This study will try to see if removing part of the thymus affects immune health over time in people aged 1 and older with Down syndrome, comparing those who had thymectomy to those who did not and to unaffected household relatives.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.